Semanta (Semaglutide)

Semanta (Semaglutide) 15 mg / 3 mL injection from Ajanta Pharma is a GLP-1 receptor agonist used for the management of type 2 diabetes and medical weight control. Semaglutide therapy has become widely used worldwide due to its effectiveness in improving blood glucose regulation and supporting weight reduction.

Semaglutide works by mimicking the natural hormone GLP-1. This hormone helps regulate blood sugar levels by stimulating insulin secretion when glucose levels rise and reducing glucagon production by the liver. These actions help stabilize blood sugar and reduce post-meal spikes.

Semanta also influences appetite regulation. By slowing gastric emptying and promoting feelings of fullness, semaglutide helps patients naturally reduce calorie intake. Many individuals using GLP-1 medications experience steady and gradual weight loss when treatment is combined with healthy lifestyle habits.

Semanta is supplied in a 15 mg semaglutide / 3 mL cartridge that provides multiple weekly doses. The medication is administered as a subcutaneous injection once per week using a pen-style injector.

Treatment usually begins with a lower weekly dose to minimize side effects. The dose may then be increased gradually depending on patient response and physician guidance. Some patients may experience mild gastrointestinal symptoms during the early stages of therapy.

In addition to improving glycemic control, semaglutide medications have shown potential cardiovascular benefits in certain patients with type 2 diabetes. Improved metabolic control and weight reduction may help support long-term health.

Semanta (Semaglutide) 15 mg / 3 mL injection should always be used under medical supervision. Patients should consult a healthcare provider before beginning treatment.